Back

To evaluate the effectiveness of primary prevention of anthracycline cardiotoxicity using modern STE technologies.

4 December 2019 (09:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Imaging: Prevention and Rehabilitation Imaging in Prevention and Rehabilitation EACVI Premium Access EuroEcho 2019

About the speaker

Photo
Assistant Professor Valeriy Nesvetov

Moscow State University Of Medicine And Dentistry, Moscow (Russian Federation)

3 More presentations in this session

Presentation thumbnail
Mr N. Jalaludeen (Cambridge, GB)
Abstract
Presentation thumbnail
Miss M. Alsharqi (Oxford, GB)
Abstract
Presentation thumbnail
Doctor A. Garcia Campos (Santiago de Compostela, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Imaging: Prevention and Rehabilitation

The Event

Event poster

EuroEcho 2019

4 December 2019 09:00 CET
You may be interested in
thumbnail
Webinar
Exercise, rehabilitation and preventive strategies in cardio-oncology
3 December 2025
thumbnail
Congress Presentation
3D strain echocardiography in detection of subclinical left ventricle dysfunction as a marker of early-onset anthracycline cardiotoxicity among children treated for acute lymphoblastic leukemia.
21 June 2025
thumbnail
Congress Presentation
HEARTOX-P: a novel multiparametric score for predicting cardiotoxicity in HER2-positive breast cancer patients undergoing chemotherapy
21 June 2025
thumbnail
Congress Presentation
Febuxostat exacerbates doxorubicin-induced cardiac remodelling in a murine model of cardiomyopathy
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources